Integrated pharmacology and experimental validation reveals potential multiple mechanisms of the neutrophil elastase inhibitor sivelestat in attenuating myocarditis.

Ren R, Wang N, Chen C, Yang M, Li B, Yang Y, Zhang H, Yang B, Wu Y, Gao W, Hou Y.

Open source

DOI: 10.3389/fphar.2026.1695352
Published: 2026-04-30
Container: Front Pharmacol
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2026.1695352,
  title = {Integrated pharmacology and experimental validation reveals potential multiple mechanisms of the neutrophil elastase inhibitor sivelestat in attenuating myocarditis.},
  author = {Ren R and  Wang N and  Chen C and  Yang M and  Li B and  Yang Y and  Zhang H and  Yang B and  Wu Y and  Gao W and  Hou Y.},
  year = {2026},
  journal = {Front Pharmacol},
  doi = {10.3389/fphar.2026.1695352},
  url = {https://doi.org/10.3389/fphar.2026.1695352}
}

RIS

TY  - JOUR
TI  - Integrated pharmacology and experimental validation reveals potential multiple mechanisms of the neutrophil elastase inhibitor sivelestat in attenuating myocarditis.
AU  - Ren R
AU  -  Wang N
AU  -  Chen C
AU  -  Yang M
AU  -  Li B
AU  -  Yang Y
AU  -  Zhang H
AU  -  Yang B
AU  -  Wu Y
AU  -  Gao W
AU  -  Hou Y.
PY  - 2026
JO  - Front Pharmacol
DO  - 10.3389/fphar.2026.1695352
UR  - https://doi.org/10.3389/fphar.2026.1695352
ER  -

APA

R, R., N, W., C, C., M, Y., B, L., Y, Y., H, Z., B, Y., Y, W., W, G., & Y., H. (2026). Integrated pharmacology and experimental validation reveals potential multiple mechanisms of the neutrophil elastase inhibitor sivelestat in attenuating myocarditis.. Front Pharmacol. https://doi.org/10.3389/fphar.2026.1695352

Source records

europe-pmc · retrieved 2026-09-27T03:40:46.572Z
doaj · retrieved 2026-09-27T03:40:46.572Z